Skip to main content
Signal8
Bitterman Chris T. profile photo

Chris T. Bitterman

CIK: 0001969681

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CUMBERLAND PHARMACEUTICALS INC logo
CPIX

CUMBERLAND PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • CUMBERLAND PHARMACEUTICALS INC logo
    CPIX

    CUMBERLAND PHARMACEUTICALS INC

    Mar 18, 2026
    Award(A)

    Options (right to buy)

    Direct
    3K shares at avg. $2.80-
  • CUMBERLAND PHARMACEUTICALS INC logo
    CPIX

    CUMBERLAND PHARMACEUTICALS INC

    Mar 17, 2025
    Award(A)

    Options (right to buy)

    Direct
    2.8K shares at avg. $5.17-

1-2 of 2

About Bitterman Chris T.

Bitterman Chris T. (SEC CIK 0001969681) files insider reports with the SEC as Vice Pres Sales & Marketing of CUMBERLAND PHARMACEUTICALS INC (CPIX).

Signal8 holds 2 ownership filings by Bitterman Chris T., all Form 4s, filed between Mar 18, 2025 and Mar 20, 2026. Those filings report 2 transactions, from Mar 17, 2025 to Mar 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bitterman Chris T.'s filings is in NASHVILLE, TN.

Recent filings by Bitterman Chris T.

  • Mar 18, 2026: Grant or award of CPIX derivative securities (Form 4, code A).
  • Mar 17, 2025: Grant or award of CPIX derivative securities (Form 4, code A).

Other insiders filing for CUMBERLAND PHARMACEUTICALS INC (CPIX)

How to read Form 4 transaction codes